SEBIVO
SEBIVO
Discontinued
DIN Number
02288389
Drug Class
Human
Market Date
Dec 14, 2006
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02288389
AIG Number0151972001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AF11 TELBIVUDINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.32
Health Canada Classification
ACTIVE INGREDIENTS (1)
TELBIVUDINEActive
Strength: 600 MG
Monograph: TELBIVUDINE